Coeptis Therapeutics Holdings, Inc.
COEP
$9.67
-$0.08-0.82%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -11.62M | -16.14M | -16.31M | -21.27M | -20.45M |
| Total Depreciation and Amortization | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M |
| Total Amortization of Deferred Charges | 150.00K | 150.00K | 150.00K | -- | -- |
| Total Other Non-Cash Items | 2.71M | 6.78M | 6.14M | 11.26M | 13.10M |
| Change in Net Operating Assets | 826.40K | 1.21M | 1.53M | 1.73M | -73.90K |
| Cash from Operations | -6.91M | -6.97M | -7.46M | -7.24M | -6.39M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00K | 250.00K | -100.00K | 0.00 | 0.00 |
| Cash from Investing | -100.00K | 250.00K | -100.00K | 0.00 | 0.00 |
| Total Debt Issued | 2.00M | -890.90K | 2.00M | 650.00K | 500.00K |
| Total Debt Repaid | -937.50K | -1.81M | -1.51M | -1.23M | -2.99M |
| Issuance of Common Stock | 2.25M | 5.79M | 5.79M | 5.29M | 3.54M |
| Repurchase of Common Stock | -500.00K | -450.00K | -- | -- | -700.00 |
| Issuance of Preferred Stock | 3.22M | 1.69M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 700.00K | 700.00K | 200.00K | 200.00K | -614.60K |
| Cash from Financing | 6.73M | 5.03M | 6.48M | 4.92M | 433.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | -- | -- | -- | 0.00 |
| Net Change in Cash | -274.10K | -1.69M | -1.08M | -2.32M | -5.96M |
